Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Marie Bleakley, MD, PhD, MMSc

Marie Bleakley, MD, PhD, MMSc

Specialties

  • Children's Title: Co-Director, High-Risk Leukemia Program
  • Academic Title: Professor, Department of Pediatrics, University of Washington School of Medicine
  • Research Title: Professor and Director, Cellular Therapy and Transplantation for Pediatric Leukemia, Translational Sciences and Therapeutics Division, Fred Hutch
  • Foundation Title: Gerdin Family Endowed Chair for Leukemia Research
  • Research Center: Ben Towne Center for Childhood Cancer and Blood Disorders Research
  • On Staff Since: November 2005
"Cancer is an enormous challenge, but what gives me hope are the new advances in immunotherapies — ways we can manipulate the immune system to fight cancer — and the resilience and strength of the young people I treat."

  • Biography

    Marie Bleakley, MD, PhD, MMSc, is a hematologist-oncologist who specializes in hematopoietic (blood-forming) stem cell transplantation for children and young adults with blood cancers. In addition to caring for patients, she serves as the co-director of the High-Risk Leukemia Program at Seattle Children’s. In this role, Dr. Bleakley collaborates with families and other physicians to develop treatment plans for patients with leukemia that has a high risk of relapse. 

    At Fred Hutchinson Cancer Center, Dr. Bleakley is the director, Cellular Therapy and Transplantation for Pediatric Leukemia; Gerdin Family Endowed Chair for Leukemia Research; and an associate professor, Clinical Research Division. She leads a lab that is focused on developing better approaches to stem cell transplantation and other cellular therapies for young patients with leukemia. The team's goal is to develop therapies that harness the cancer-fighting power of T cells (a type of immune cell) while also reducing the incidence of graft-versus-host disease, a potentially life-threatening side effect of transplantation. Dr. Bleakley is the principal investigator of multiple ongoing clinical trials in these areas. 

    Board Certification(s)

    Pediatric Hematology-Oncology

    Research Focus Area

    Allogeneic hematopoietic stem cell transplantation, High-risk leukemias, T cell immunotherapy

  • Related Resources

  • Patient Testimonials

  • Awards and Honors

    Award Name Award Description Awarded By Award Date
    {{ award.name }} {{ award.description }} {{ award.organization }} {{ award.displayDate }}

  • Publications

    Loading...

    No Publications found for Marie Bleakley, MD, PhD, MMSc

  • Presentations

    Presentation Title Event Location Date
    {{ presentation.title }} {{ presentation.presentedAt }} {{ presentation.location }} {{ presentation.displayDate }}

  • Research Funding

    Grant Title Grantor Amount Award Date
    {{ funding.title }} {{ funding.grantedBy }} {{ funding.amount }} {{ funding.displayDate }}

  • Clinical Trials and Research Studies

    {{ item.t }}

    {{ item.st }}

    {{ item.obj }}

    Condition(s): {{ item.con }} Phase: {{ item.ph }} Clinicaltrials.gov ID: {{ item.nct }}

    No clinical trials found for Marie Bleakley, MD, PhD, MMSc.

Contact Information

Primary Office

Fred Hutchinson Cancer Center
1100 Fairview Ave N
PO Box 19024 - MS D3-100
Seattle, WA 98109-1024
Tel: 206-667-6770

Make an Appointment Refer a Patient

Find a Doctor or Researcher

Type the first or last name you are searching for or select a specialty.

  • Doctor or Researcher Name:
More search options Less search options